Biogen has entered into significant agreements with Apellis Pharmaceuticals, including a Credit Agreement and Contingent Value Rights, and is now incurring integration costs.
Filing excerpt
Contingent Value Rights Agreement, dated as of May 14, 2026, by and among Biogen, Apellis and Equiniti Trust Company, LLC (incorporated herein by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by Biogen with the SEC on May 14, 2026).
What this signalsIntegration work after a deal often opens needs for new systems and services.
Vendors
Vendors named
sec-10qacquisitionAnnouncedGet every 10-Q signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c7fa042e-3b47-4402-91ed-7b7848f4850a returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "c7fa042e-3b47-4402-91ed-7b7848f4850a",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-08-04T07:06:05.023+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Biogen has entered into significant agreements with Apellis Pharmaceuticals, including a Credit Agreement and Contingent Value Rights, and is now incurring integration costs. This large-scale integration creates immediate needs for systems consolidation (IT, HR, finance), process harmonization, and change management consulting.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "Biogen in process of major integration with Apellis Pharmaceuticals following May 2026 agreements.",
"excerpts": "Contingent Value Rights Agreement, dated as of May 14, 2026, by and among Biogen, Apellis and Equiniti Trust Company, LLC (incorporated herein by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by Biogen with the SEC on May 14, 2026).",
"relevance": 0.95,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000075/biib-20260630.htm",
"filing_date": "2026-07-29",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic",
"vendors_mentioned": [
"Apellis Pharmaceuticals Inc.",
"Equiniti Trust Company, LLC",
"U.S. Bank National Association"
]
}
}
curl https://signals.autobound.ai/v1/signals/c7fa042e-3b47-4402-91ed-7b7848f4850a \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.